Spironolactone Tablet
Product Images NDC 65162-515

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 65162-515). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

10 (Spironolactone Tablets Usp Us 1)

10 (Spironolactone Tablets Usp Us 1)
Chemical structure of spironolactone, depicted as a molecular diagram with labeled chemical groups and bonds.*
FDA Label Image

10 (Spironolactone Tablets Usp Us 2)

10 (Spironolactone Tablets Usp Us 2)
A Kaplan-Meier survival probability curve comparing Spironolactone and placebo groups over time in months. The graph shows probability on the y-axis and months on the x-axis, with separate lines indicating outcomes for Spironolactone (n=822) and placebo (n=841). A log-rank p-value of less than 0.001 is noted.*
FDA Label Image

10 (Spironolactone Tablets Usp Us 3)

10 (Spironolactone Tablets Usp Us 3)
A forest plot chart showing hazard ratios (HR) and 95% confidence intervals (CI) for Spironolactone versus placebo across various subgroups, including age, sex, race, left ventricular ejection fraction (LVEF), heart failure type, NYHA class, diabetes status, serum creatinine levels, creatinine clearance, potassium levels, digoxin use, ACE inhibitor use, and beta blocker use. The horizontal axis indicates the relative effect, with Spironolactone favored on the left and placebo on the right.*
FDA Label Image

1 (Spironolactone Tablets Usp Us 4)

1 (Spironolactone Tablets Usp Us 4)
Spironolactone Tablets, USP 25 mg oral tablets in a package label showing 30 tablets. The label includes the dosage strength, manufacturer Amneal Pharmaceuticals LLC, storage instructions, and a barcode. The label states Rx only and lists the distributor's location as Bridgewater, NJ.*
FDA Label Image

2 (Spironolactone Tablets Usp Us 5)

2 (Spironolactone Tablets Usp Us 5)
Label for Spironolactone Tablets USP 50 mg, oral tablets, by Amneal Pharmaceuticals LLC. The label indicates a package containing 30 tablets. It includes storage instructions and distributor information along with a barcode and a non-varnish area note for lot and expiration date.*
FDA Label Image

3 (Spironolactone Tablets Usp Us 6)

3 (Spironolactone Tablets Usp Us 6)
Label for Spironolactone Tablets, USP 100 mg by Amneal Pharmaceuticals LLC. The label indicates 30 tablets per container, prescription use only, with storage instructions at 20° to 25°C (68° to 77°F). The label includes a barcode and states the product is distributed by Amneal Pharmaceuticals LLC, Bridgewater, NJ.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.